New supplier contracts awarded

Our Future Health | 08.03.22

Our Future Health is announcing new supplier contracts that have been awarded.

These contracts will play an important role in helping us to achieve our aim of transforming the prevention, detection and treatment of conditions such as dementia, cancer, diabetes, heart disease and stroke, so future generations can live in good health for longer. 

Genotype assay design and manufacture

The contract for genotype assay design and manufacture has been awarded to Illumina Cambridge Ltd.   

This involves the design, manufacture and quality control assessment for a genotype assay that will be used to process up to 5 million samples donated by volunteers.

Biological sample receipt & processing – Wales

The contract for biological sample receipt & processing for Wales has been awarded to Randox Laboratories. This involves processing the blood samples for up to 250,000 volunteers. The processing includes blood sample receipting, fraction separation by centrifugation, and DNA extraction.

Genotyping service supplier

The contract for genotyping service supplier had been awarded to Eurofins.

This involves conducting genotype calling, using the assay design by the above supplier. The results of this genotyping will be provided to Our Future Health.

More awards coming soon

We will update this page as details of other contracts awarded are available. We will update this news story as details of the other contracts we have awarded are available.

Stay in touch

To stay updated with the latest news from Our Future Health, sign up to our newsletter.